Genetic alterations in endometrial cancer by targeted next-generation sequencing.
Experimental and molecular pathology 2015 Nov .
Chang Ya-Sian, Huang Hsien-Da, Yeh Kun-Tu, Chang Jan-Gow
Second-line dovitinib (TKI258) in patients with FGFR2-mutated or FGFR2-non-mutated advanced or metastatic endometrial cancer: a non-randomised, open-label, two-group, two-stage, phase 2 study.
The Lancet. Oncology 2015 Jun 16 (6): 686-94.
Konecny Gottfried E, Finkler Neil, Garcia Agustin A, Lorusso Domenica, Lee Paula S, Rocconi Rodney P, Fong Peter C, Squires Matt, Mishra Kaushal, Upalawanna Allison, Wang Yongyu, Kristeleit Rebec